Dr. Cheshmedzhieva, Vice-President, Global Clinical Development, Celerion will present at #vaccine 2020 Virtual Conference on Aug 12. Please join us for an insightful presentation. arena-international.com/vaccine-virtua…

Celerion is a ‘one-stop shop’ for #ADME and #Metabolic ID studies. With this new service offering, we complement our experience and expertise in human ADME with innovative Metabolic ID analysis by high-resolution #massspectrometry (HRMS). businesswire.com/news/home/2020…

Celerion offers a comprehensive platform of #COVID19 bioassays, including #PCR screening, viral load quantification, antibody titer measurement and more to support our clients’ studies moving forward during the pandemic. celerion.com/2020/06/18/ope…

Continuing our 10-year Anniversary as Celerion, this month we are highlighting Celerion’s Top 10 #Innovative #Technologies Implemented over the Past Decade. A Decade of Translating Science into Medicine. August’s 10 Celerion Innovative Technology. celerion.com/2020/08/04/a-d…

A Decade of Translating Science into Medicine. August’s 10 Celerion Innovative Technology. In 2020, Celerion delivers the Future of Pharmacy with state-of-the-art #pharmacy suites for extemporaneous API compounding. youtu.be/n7HyuMJVQ_o celerion.com/pharmacy

Closer to a Cure. Celerion is launching a brand new #covid19 page. Visit our site for latest #covid19 news, presentations, blog articles and links to regulatory guidance. #CloserToACure celerion.com/covid-19

Our extensive #ADME experience includes nearly 100 radiolabelled clinical studies. We now complement this service with High-Resolution #MassSpectrometry for detailed metabolic profiling: celerion.com/resource/metab…

Celerion’s proven #vaccine experience is built on comprehensive #bioanalytical services, a long history on Phase I/II studies in healthy volunteers and our global vaccine site network with access to patients. celerion.com/wp-content/upl…

How to execute a #vaccine study during the pandemic? Could hybrid study design approach decrease proof of concept timeline? Join Dr. Zori Cheshmedzhieva, Vice-President, Global Clinical Development for an exciting presentation at the vaccine conference. bit.ly/31uMGtm

Hot or cold? We offer #metabolite identification for both radiolabeled and non-radiolabeled studies with our new service offering of high-resolution #massspectrometry (HRMS). celerion.com/resource/adme-…

Dr. Zori Cheshmedzhieva, Vice-President, Global Clinical Development, Celerion is presenting: Faster Forward with Accelerated First in Human(FIH) to Proof Of Concept(POC) Early Phase Vaccine Trials at 9:30am EST at Vaccine 2020 Virtual Conference. arena-international.com/vaccine-virtua…

Vaccine development is typically a long game. With the COVID-19 crisis underway, speedy vaccine development is imperative. See how Celerion can support your vaccine studies: celerion.com/wp-content/upl…

Welcome Timothy Sangster join Celerion as the Executive Director, Bioanalytical Sciences, Celerion！ #bioanalytical prnewswire.com/news-releases/…

Kate Reese, PharmD, Director, Regulatory Science will present How US Regulatory Pharmacy Requirements Impact Early Phase Clinical Pharmacology Studies on Aug 26. Join us and Register Now: bigmarker.com/bioalliance-vi…

A Decade of Translating Science into Medicine. Celerion’s Top 10 Innovative Technologies- FibroScan® FibroScan® is a noninvasive ultrasound-like device that simultaneously measures liver fat and fibrosis. Introduced to our clinics in 2018. #NASH celerion.com/wp-content/upl…

Celerion’s lead biomarker scientists, Sumit Kar, describes how ultrasensitive technology can accurately measure IL-1β in #NASH patients and demonstrates the need for fit-for-purpose validation based on COU to drive #biomarker #bioanalytical validation. youtube.com/watch?v=9Yf0tn…

A Decade of Translating Science into Medicine. One of Celerion’s Top 10 Innovative Technologies- Celexus® #clinicaltrials #drugdevelopment celerion.com/innovations/ce…

Did you miss the presentation: Faster Forward with Accelerated First in Human to Proof Of Concept Early Phase Vaccine Trials from Dr. Zori Cheshmedzhieva, VP, Celerion at Vaccine 2020 Virtual Conference? The recording is available online now: youtu.be/bDpMy8XyY7I

Celerion has proven experience across a variety of #vaccines, including different routes of administration, and patient populations. Our track record spans both preventive and therapeutic vaccines, subunit and conjugates across all phases I-IV. bit.ly/319aMei

In the past 5 years, #Celerion has run more than 30 renal impairment studies. In a quarter of them, the reduced design option saved clients time & money. Our experts can provide insight into how the revised draft guidance can benefit you rb.gy/hgnnyc #RenalImpairment